Pfizer Group President & Chief Business Officer John D. Young to retire in early 2022

PFIZER INC

John D. Young announced retirement, stepping down as executive officer no later than Dec 31, 2021.
He will remain as an employee in an advisory role for part of 2022 after stepping down.
Young was Group President and Chief Business Officer at Pfizer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John D. Young

Group President, Chief Business Officer

PFE · PFIZER INC

Effective: 2021-12-31
Filed: July 9, 2021, 7:59 PM ET

John D. Young, Group President, Chief Business Officer, has announced his decision to retire from Pfizer Inc. (the “Company”) in early 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John D. Young retired as Group President, Chief Business Officer at PFIZER INC.

Action: retired
Role: Group President, Chief Business Officer

Exact text from the filing

John D. Young, Group President, Chief Business Officer, has announced his decision to retire from Pfizer Inc. (the “Company”) in early 2022.

View on SEC.gov

PFIZER INC filing history →

Source: SEC EDGAR

accession 0000078003-21-000087

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.